KFSP4, KFA2-GG-SP(4-11)

General Information


DRACP ID  DRACP04412

Peptide Name   KFSP4, KFA2-GG-SP(4-11)

Sequence  KFAKFAKKFAKFAKGGPQQFFGLM

Sequence Length  24

UniProt ID  P20366 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C134H200N32O27S

Absent amino acids  CDEHINRSTVWY

Common amino acids  FK

Mass  313375

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  11

Net charge  6

Boman Index  -917

Hydrophobicity  -14.58

Aliphatic Index  32.92

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31953126

Title  Enhanced cell selectivity of hybrid peptides with potential antimicrobial activity and immunomodulatory effect

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19639

DRACP is developed by Dr.Zheng's team.